Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Partner Content Partner Content Patient Organisations role in Orphan Drugs clinical developm... Orphan Drugs and Rare Diseases Conference - London
Partner Content Partner Content Registration is open for the 9th Annual Biosimilars & Bi... Biosimilars & Biobetters conference information
News Orphan drugs dominate 2018 UK Prix Galien shortlist A bumper crop of orphan drugs from the likes of Amicus, Kyowa Kirin, Eusa and Biogen dominates this year’s UK Prix Galien shortlist as biotech firms and specialist pharma companies cement t
Partner Content Partner Content Official Agenda released for 8th annual Orphan Drugs and Rar... Agenda released for 8th Orphan Drugs and Rare Diseases
Events Partner Content BioTech Pharma Summit: Biosimilars & Biologics 2018 Biosimilars & Biologics:The future of Biotech Medicines
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
